Anti-inflammatory Therapy for Sarcoidosis

Prognostic Factors and Treatments Efficacy in Spinal Cord Sarcoidosis: An Observational Cohort With Long-term Follow-up

(2022) Antoine Gavoille et al.   NEUROLOGY

Hit-hard and early versus step-up treatment in severe sarcoidosis

(2022) Adriane D.M. Vorselaars et al.   CURRENT OPINION IN PULMONARY MEDICINE

Novel insights in fibrotic pulmonary sarcoidosis

(2022) Alessia Comes et al.   CURRENT OPINION IN PULMONARY MEDICINE

Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

(2022) William Damsky et al.   Nature Communications

Tofacitinib for sarcoidosis, a new potential treatment

(2022) Qiang Xu et al.   International Journal of Rheumatic Diseases

Epidemiology, clinical presentation, treatment, and outcome of neurosarcoidosis: A mono-centric retrospective study and literature review

(2022) Pauline Sambon et al.   Frontiers in Neurology

Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches

(2022) Ogugua Ndili Obi et al.   Frontiers in Medicine

Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data

(2021) Marios Rossides et al.   RESPIROLOGY

Effectiveness and safety of infliximab in cardiac Sarcoidosis

(2021) A.L.M. Bakker et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Switching to an Infliximab Biosimilar Was Safe and Effective in Dutch Sarcoidosis Patients

(2021) Bas J. M. Peters et al.   Cells

Tofacitinib as a Steroid-Sparing Therapy in Pulmonary Sarcoidosis, an Open-Label Prospective Proof-of-Concept Study

(2021) Marcia A. Friedman et al.   LUNG

Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study

(2021) Loredana La Mantia et al.   NEUROLOGICAL SCIENCES

A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc

(2021) Lesley Ann Saketkoo et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)

(2021) Henrik Pettersson et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

ERS clinical practice guidelines on treatment of sarcoidosis

(2021) Robert P. Baughman et al.   EUROPEAN RESPIRATORY JOURNAL

Management of Cardiac Sarcoidosis Using Mycophenolate Mofetil as a Steroid-Sparing Agent

(2021) Jan M. Griffin et al.   JOURNAL OF CARDIAC FAILURE

Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience

(2021) MOHAMED ELWAZIR et al.   JOURNAL OF CARDIAC FAILURE

Challenges of Sarcoidosis and Its Management

(2021) Marjolein Drent et al.   NEW ENGLAND JOURNAL OF MEDICINE

Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review

(2021) Siavosh Fazelpour et al.   Journal of the American Heart Association

Efficacy and Tolerability of Methotrexate and Methylprednisolone in a Comparative Assessment of the Primary and Long-Term Outcomes in Patients with Pulmonary Sarcoidosis

(2021) Volodymyr Gavrysyuk et al.   Diagnostics

Case Report: TNFα Antagonists Are an Effective Therapy in Cardiac Sarcoidosis

(2021) Julien Stievenart et al.   Frontiers in Cardiovascular Medicine

Glucocorticoid sparing in sarcoidosis using the JAK inhibitor tofacitinib

(2021) Julie BELLIERE et al.   European Journal of Internal Medicine

Atteinte rénale au cours de la sarcoïdose : facteurs pronostiques et prédictifs

(2021) Imen Gorsane et al.   Nephrologie & Therapeutique

The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study

(2021) Ying Zhou et al.   RESPIRATORY MEDICINE

2020 NAEPP Guidelines Update and GINA 2021—Asthma Care Differences, Overlap, and Challenges

(2021) Bradley E. Chipps et al.   Journal of Allergy and Clinical Immunology-In Practice

Neurosarcoidosis

(2021) Michael J. Bradshaw et al.   Neurology-Neuroimmunology & Neuroinflammation

Physiological Predictors of Survival in Patients with Sarcoidosis Associated Pulmonary Hypertension: Results from an International Registry

(2020) Oksana A. Shlobin et al.   EUROPEAN RESPIRATORY JOURNAL

The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review

(2020) Roeland Vis et al.   European Respiratory Review

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline

(2020) Elliott D. Crouser et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Randomised, placebo-controlled trial of dexamethasone for quality of life in pulmonary sarcoidosis

(2020) Roeland Vis et al.   RESPIRATORY MEDICINE

Refractory Sarcoidosis: A Review

(2020) Thomas El Jammal et al.   Therapeutics and Clinical Risk Management

Neurosarcoidosis

(2020) Jennifer Lord et al.   Neurology-Neuroimmunology & Neuroinflammation

Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study

(2020) Franck F. Rahaghi et al.   European Respiratory Review

Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis

(2020) Franck F. Rahaghi et al.   European Respiratory Review

Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide

(2020) Lily J. Henson et al.   REPRODUCTIVE TOXICOLOGY

Predictors of mortality in fibrosing pulmonary sarcoidosis

(2020) Florence Jeny et al.   RESPIRATORY MEDICINE

Advanced Pulmonary Sarcoidosis

(2020) Rohit Gupta et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Infliximab treatment in pathology-confirmed neurosarcoidosis

(2020) Daan Fritz et al.   Neurology-Neuroimmunology & Neuroinflammation

Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observational Study

(2020) Laixi Xue et al.   Frontiers in Medicine

Clinical and Imaging Response to Tumor Necrosis Factor Alpha Inhibitors in Treatment of Cardiac Sarcoidosis: A Multicenter Experience

(2020) Nisha A. Gilotra et al.   JOURNAL OF CARDIAC FAILURE

Tofacitinib for cutaneous and pulmonary sarcoidosis: a case series

(2020) Karolina L. Kerkemeyer et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Challenges in Cardiac and Pulmonary Sarcoidosis

(2020) Maria Giovanna Trivieri et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiac sarcoidosis: A long term follow up study

(2020) Patrice Cacoub et al.   PLoS One

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study

(2020) Vivienne Kahlmann et al.   BMC Pulmonary Medicine

Treatment of Sarcoidosis: A Multidisciplinary Approach

(2020) Alicia K. Gerke   Frontiers in Immunology

The Burden of Sarcoidosis Symptoms from a Patient Perspective

(2019) M. Voortman et al.   LUNG

A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis

(2019) Katie Bechman et al.   RHEUMATOLOGY

Sarcoidosis

(2019) Johan Grunewald et al.   Nature Reviews Disease Primers

Infliximab for Refractory Cardiac Sarcoidosis

(2019) Logan J. Harper et al.   AMERICAN JOURNAL OF CARDIOLOGY

Nonorgan manifestations of sarcoidosis

(2019) Jinny Tavee et al.   CURRENT OPINION IN PULMONARY MEDICINE

Advanced sarcoidosis

(2019) Robert P. Baughman et al.   CURRENT OPINION IN PULMONARY MEDICINE

Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis

(2019) David G. Rosenthal et al.   Journal of the American Heart Association

Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)

(2019) David Birnie et al.   AMERICAN HEART JOURNAL

Predictors of Mortality in Pulmonary Sarcoidosis

(2018) Gamze Kirkil et al.   CHEST

Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists

(2018) Hiroki Mitoma et al.   CYTOKINE

Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes

(2018) Caroline E. Broos et al.   EUROPEAN RESPIRATORY JOURNAL

Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis

(2018) Caroline E. Broos et al.   EUROPEAN RESPIRATORY JOURNAL

Th17-lineage cells in pulmonary sarcoidosis and Löfgren's syndrome: Friend or foe?

(2018) Jelle R. Miedema et al.   JOURNAL OF AUTOIMMUNITY

Efficacy and safety of infliximab biosimilar Inflectra ® in severe sarcoidosis

(2018) Milou C. Schimmelpennink et al.   RESPIRATORY MEDICINE

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients

(2018) Claudia Fabiani et al.   CLINICAL RHEUMATOLOGY

Neurosarcoidosis: clinical characteristics, diagnosis, and treatment in eight Chinese patients

(2018) Fen Wang et al.   NEUROLOGICAL SCIENCES

Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis

(2018) William Damsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Repository corticotropin for Chronic Pulmonary Sarcoidosis

(2017) Robert P. Baughman et al.   LUNG

Infliximab for the treatment of CNS sarcoidosis

(2017) Jeffrey M. Gelfand et al.   NEUROLOGY

Sarcoidosis-associated small fiber neuropathy in a large cohort: Clinical aspects and response to IVIG and anti-TNF alpha treatment

(2017) Jinny O. Tavee et al.   RESPIRATORY MEDICINE

Toxicity risk from glucocorticoids in sarcoidosis patients

(2017) Nauman A. Khan et al.   RESPIRATORY MEDICINE

Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients

(2017) Yvan Jamilloux et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis

(2017) Valentine Heidelberger et al.   JAMA Dermatology

Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis

(2017) Bastien Joubert et al.   JAMA Neurology

The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial

(2017) Kevin L. Winthrop et al.   Arthritis & Rheumatology

Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature

(2017) Tong Zhou et al.   Scientific Reports

Effect of Discontinuation of Prednisolone Therapy on Risk of Cardiac Mortality Associated With Worsening Left Ventricular Dysfunction in Cardiac Sarcoidosis

(2016) Toshiyuki Nagai et al.   AMERICAN JOURNAL OF CARDIOLOGY

Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis

(2016) Z. Jiyad et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis

(2016) Daan Fritz et al.   BMC Neurology

Multicenter Experience With Mycophenolate Mofetil in Cardiac Sarcoidosis

(2016) Lynn Fussner et al.   CHEST

FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab

(2016) Christina T. Miller et al.   CLINICAL NUCLEAR MEDICINE

Sarcoidosis: an update on current pharmacotherapy options and future directions

(2016) Pilar Brito-Zerón et al.   EXPERT OPINION ON PHARMACOTHERAPY

High azathioprine dose and lip cancer risk in liver, heart, and lung transplant recipients: A population-based cohort study

(2016) Renhua Na et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Treatment of neurosarcoidosis

(2016) Samuel Bitoun et al.   NEUROLOGY

Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab

(2016) Heleen A. Crommelin et al.   RESPIRATORY MEDICINE

A retrospective pilot study examining the use of Acthar gel in sarcoidosis patients

(2016) Robert P. Baughman et al.   RESPIRATORY MEDICINE

Corticosteroids in Sarcoidosis

(2016) Marc A. Judson   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Managing fatigue in sarcoidosis – A systematic review of the evidence

(2016) Chris Atkins et al.   Chronic Respiratory Disease

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network

(2016) Hélène Vallet et al.   Arthritis & Rheumatology

Physical activity and training in sarcoidosis: review and experience-based recommendations

(2016) Bert Strookappe et al.   Expert Review of Respiratory Medicine

Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis

(2015) Adriane D.M. Vorselaars et al.   EUROPEAN RESPIRATORY JOURNAL

Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years

(2015) R. F. van Vollenhoven et al.   JOURNAL OF RHEUMATOLOGY

Benefits of Physical Training in Sarcoidosis

(2015) Bert Strookappe et al.   LUNG

The effect of corticosteroids on quality of life in a sarcoidosis clinic: The results of a propensity analysis

(2015) Marc A. Judson et al.   RESPIRATORY MEDICINE

Successful use of rituximab in refractory cardiac sarcoidosis

(2015) Megan L. Krause et al.   RHEUMATOLOGY

Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients

(2015) Leyre Riancho-Zarrabeitia et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

ACTH: The forgotten therapy

(2015) Trinidad Montero-Melendez   SEMINARS IN IMMUNOLOGY

Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials

(2015) Vibeke Strand et al.   ARTHRITIS RESEARCH & THERAPY

New treatment strategies for pulmonary sarcoidosis: antimetabolites, biological drugs, and other treatment approaches

(2015) Robert P Baughman et al.   Lancet Respiratory Medicine

Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity

(2014) P.H. Schafer et al.   CELLULAR SIGNALLING

Apremilast: First Global Approval

(2014) Raewyn M. Poole et al.   DRUGS

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis

(2014) M. A. Judson et al.   EUROPEAN RESPIRATORY JOURNAL

Rituximab in the treatment of refractory pulmonary sarcoidosis

(2014) N. J. Sweiss et al.   EUROPEAN RESPIRATORY JOURNAL

Association of the TNF-  G-308A polymorphism with TNF-inhibitor response in sarcoidosis

(2014) P. A. Wijnen et al.   EUROPEAN RESPIRATORY JOURNAL

Treatment with Methotrexate and Low-dose Corticosteroids in Sarcoidosis Patients with Cardiac Lesions

(2014) Sonoko Nagai et al.   INTERNAL MEDICINE

Striking leflunomide efficacy against refractory cutaneous sarcoidosis

(2014) Gérôme Bohelay et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy of mycophenolate mofetil in sarcoidosis

(2014) Nabeel Hamzeh et al.   RESPIRATORY MEDICINE

An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study

(2014) Simon LF Walsh et al.   Lancet Respiratory Medicine

Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease

(2013) Björn Pasternak et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Corticosteroid Therapy for Cardiac Sarcoidosis: A Systematic Review

(2013) Mouhannad M. Sadek et al.   CANADIAN JOURNAL OF CARDIOLOGY

Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis

(2013) Adriane D.M. Vorselaars et al.   CHEST

Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis

(2013) Johanna P. Cremers et al.   CURRENT OPINION IN PULMONARY MEDICINE

Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis

(2013) A. D. M. Vorselaars et al.   EUROPEAN RESPIRATORY JOURNAL

Successful Treatment of Ocular Sarcoidosis with Rituximab

(2013) Enrico Beccastrini et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

The potential additional benefit of infliximab in patients with chronic pulmonary sarcoidosis already receiving corticosteroids: A retrospective analysis from a randomized clinical trial

(2013) Marc A. Judson et al.   RESPIRATORY MEDICINE

Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy

(2013) Eric Russell et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Granuloma Formation in Pulmonary Sarcoidosis

(2013) Caroline E. Broos et al.   Frontiers in Immunology

Multiple Sclerosis, Relapses, and the Mechanism of Action of Adrenocorticotropic Hormone

(2013) Amy Perrin Ross et al.   Frontiers in Neurology

Sarcoidosis-associated fatigue

(2012) Marjolein Drent et al.   EUROPEAN RESPIRATORY JOURNAL

A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis

(2012) Robert J. Pariser et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Active Chronic Sarcoidosis is Characterized by Increased Transitional Blood B Cells, Increased IL-10-Producing Regulatory B Cells and High BAFF Levels

(2012) Anne Saussine et al.   PLoS One

Effect and Safety of Mycophenolate Mofetil in Chronic Pulmonary Sarcoidosis: A Retrospective Study

(2012) Anne-Kathrin Brill et al.   RESPIRATION

Efficacy and Safety of TNF Antagonists in Sarcoidosis: Data from the Spanish Registry of Biologics BIOBADASER and a Systematic Review

(2012) Jose Ramon Maneiro et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Sarcoidosis-related Mortality in the United States from 1988 to 2007

(2011) Jeffrey J. Swigris et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Efficacy and Safety of Apremilast in Chronic Cutaneous Sarcoidosis

(2011) Robert P. Baughman   ARCHIVES OF DERMATOLOGY

Disturbed Homeostasis and Multiple Signaling Defects in the Peripheral Blood B-Cell Compartment of Patients with Severe Chronic Sarcoidosis

(2011) Nam-Sihk Lee et al.   Clinical and Vaccine Immunology

Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation

(2011) Gunter Rappl et al.   CLINICAL IMMUNOLOGY

Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET

(2011) Nils Milman et al.   Clinical Respiratory Journal

Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies

(2011) Helene Alexanderson et al.   CURRENT OPINION IN RHEUMATOLOGY

Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis

(2011) D. H. Sahoo et al.   EUROPEAN RESPIRATORY JOURNAL

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis

(2011) R. J. Erckens et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy

(2011) G. Androdias et al.   NEUROLOGY

Long-Term Treatment with Infliximab in Patients with Sarcoidosis

(2011) Katrin E. Hostettler et al.   RESPIRATION

Infliximab no tratamento da sarcoidose - Experiência de um hospital central

(2011) M. Aguiar et al.   Revista Portuguesa de Pneumologia

Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study

(2010) Richard G Armstrong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

New understanding and approaches to treatment in rheumatoid arthritis

(2010) J. H. Tayar et al.   BRITISH MEDICAL BULLETIN

The CD4 + Lymphopenic Sarcoidosis Phenotype Is Highly Responsive to Anti-Tumor Necrosis Factor-α Therapy

(2010) Elliott D. Crouser et al.   CHEST

A CASE OF NEUROSARCOIDOSIS SUCCESSFULLY TREATED WITH RITUXIMAB

(2010) R. Bomprezzi et al.   NEUROLOGY

Infliximab et sarcoïdose chronique. L’expérience française à propos de 31 cas

(2010) F. Jounieaux et al.   REVUE DES MALADIES RESPIRATOIRES

Sarcoidosis is a Th1/Th17 multisystem disorder

(2010) M. Facco et al.   THORAX

Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases

(2010) Georg Schett et al.   Therapeutic Advances in Musculoskeletal Disease

FoxP3+ Regulatory T Cells Suppress Early Stages of Granuloma Formation but Have Little Impact on Sarcoidosis Lesions

(2009) Cécile Taflin et al.   AMERICAN JOURNAL OF PATHOLOGY

Efficacy of Short-Course, Low-Dose Corticosteroid Therapy for Acute Pulmonary Sarcoidosis Exacerbations

(2009) Brian P. McKinzie et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis

(2009) PH Schafer et al.   BRITISH JOURNAL OF PHARMACOLOGY

Changes in Chest Roentgenogram of Sarcoidosis Patients During a Clinical Trial of Infliximab Therapy

(2009) Robert P. Baughman et al.   CHEST

Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil

(2009) M. Moravan et al.   NEUROLOGY

Mycophenolate Mofetil Therapy for Sarcoidosis-Associated Uveitis

(2009) Pooja Bhat et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Clinical outcomes in sarcoidosis after cessation of infliximab treatment

(2009) Efstratios PANSELINAS et al.   RESPIROLOGY

The Treatment of Lupus Pernio

(2008) Eleni Stagaki et al.   CHEST

The Immunology of Sarcoidosis

(2008) Alicia K. Gerke et al.   CLINICS IN CHEST MEDICINE

Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial

(2008) M. A. Judson et al.   EUROPEAN RESPIRATORY JOURNAL

Rituximab as a treatment alternative in sarcoidosis

(2008) Ahlam Belkhou et al.   JOINT BONE SPINE

Treatment of refractory neurosarcoidosis with Infliximab

(2008) E. Santos et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Comparison of Antimetabolite Drugs as Corticosteroid-Sparing Therapy for Noninfectious Ocular Inflammation

(2008) Anat Galor et al.   OPHTHALMOLOGY

Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis

(2008) Manica Sodhi et al.   RESPIRATORY MEDICINE